Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
1 Nederlandse hepatologie in historisch en toekomstig perspectief hoofdstuk lezen eerste hoofdstuk lezen

2009 | OriginalPaper | Hoofdstuk

8 Leverziekten, ondervoeding en voeding

Auteur : Prof.dr. E.M.H. Mathus-Vliegen

Gepubliceerd in: Leverziekten

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

De lever is nauw betrokken bij de voeding en het metabolisme van koolhydraten, eiwitten en vetten.[1][2][3][4] Dankzij de glycogeensynthese, de glycogenolyse en de gluconeogenese in de lever wordt de bloedglucosespiegel binnen nauwe grenzen constant gehouden.
vorige hoofdstuk 7 Leverfalen
volgende hoofdstuk 9 Virale hepatitis
Literatuur
1.
Cabré E, Gassull MA. Nutritional aspects of chronic liver disease. Clin Nutr 1993;12(Suppl 1):S52–S63.CrossRef
2.
Cabré E, Gassull MA. Nutrition in chronic liver disease and liver transplantation. Curr Opin Clin Nutr Metab Care 1998;1(5):423–430.PubMedCrossRef
3.
Aranda-Michel J. Nutrition in hepatic failure and liver transplantation. Curr Gastroenterol Rep 2001;3(4):362–370.PubMedCrossRef
4.
5.
Cabré E, Gassull MA. Nutritional support in liver disease. Eur J Gastroenterol Hepatol 1995;7(6):528–532.PubMed
6.
Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis. J Hepatol 1994;21(3):317–325.
7.
Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997;16:43–55.PubMedCrossRef
8.
9.
Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 2003;22(3):321–336.PubMedCrossRef
10.
Kondrup J. Nutrition in end stage liver disease. Best Pract Res Clin Gastroenterol 2006;20(3):547–560.PubMedCrossRef
11.
Merli M, Romiti A, Riggio O, Capocaccia L. Optimal nutritional indexes in chronic liver disease. J Parenter Enteral Nutr 1987;11(5 Suppl):130S–134S.CrossRef
12.
Figueiredo FA, Dickson ER, Pasha TM, Porayko MK, Therneau TM, Malinchoc M,et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000;6(5):575–581.PubMedCrossRef
13.
Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? Hepatology 1996;23(5):1041–1046.PubMedCrossRef
14.
Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G,et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17(6):445–450.PubMedCrossRef
15.
Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003;19(6):515–521.PubMedCrossRef
16.
Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE, Jeejeebhoy KN. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. J Parenter Enteral Nutr 1984;8(2):153–159.CrossRef
17.
Alvares-da-Silva MR, Reverbel dS. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005;21(2):113–117.PubMedCrossRef
18.
Mendenhall C, Bongiovanni G, Goldberg S, Miller B, Moore J, Rouster S,et al. VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein–calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. J Parenter Enteral Nutr 1985;9(5):590–596.CrossRef
19.
Mendenhall CL, Tosch T, Weesner RE, Garcia-Pont P, Goldberg SJ, Kiernan T,et al. VA Cooperative Study on Alcoholic Hepatitis. II: Prognostic significance of protein– calorie malnutrition. Am J Clin Nutr 1986;43(2): 213–218.PubMed
20.
Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991;86(2):210–216.PubMed
21.
Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH,et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. J Parenter Enteral Nutr 1995;19(4):258–265.CrossRef
22.
Morgan TR, Moritz TE, Mendenhall CL, Haas R. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. J Am Coll Nutr 1995;14(2):152–158.PubMedCrossRef
23.
Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein–calorie malnutrition in liver cirrhosis. Clin Investig 1992;70(6):478–486.PubMedCrossRef
24.
Thuluvath PJ, Triger DR. Evaluation of nutritional status by using anthropometry in adults with alcoholic and nonalcoholic liver disease. Am J Clin Nutr 1994; 60(2):269–273.PubMed
25.
Caregaro L, Alberino F, Amodio P, Merkel C, Bolognesi M, Angeli P,et al. Malnutrition in alcoholic and virusrelated cirrhosis. Am J Clin Nutr 1996;63(4):602–609.PubMed
26.
Sarin SK, Dhingra N, Bansal A, Malhotra S, Guptan RC. Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease. Am J Gastroenterol 1997;92(5): 777–783.PubMed
27.
Hasse JM, Blue LS, Liepa GU, Goldstein RM, Jennings LW, Mor E,et al. Early enteral nutrition support in patients undergoing liver transplantation. J Parenter Enteral Nutr 1995;19(6):437–443.CrossRef
28.
Harrison J, McKiernan J, Neuberger JM. A prospective study on the effect of recipient nutritional status on outcome in liver transplantation. Transpl Int 1997; 10(5):369–374.PubMedCrossRef
29.
Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992;15(5):782–794.PubMedCrossRef
30.
Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller MJ. Identification of high– and low–risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997;25(3):652–657.PubMedCrossRef
31.
32.
Lieber CS. Herman Award Lecture 1993: A personal perspective on alcohol, nutrition, and the liver. Am J Clin Nutr 1993;58(3):430–442.PubMed
33.
34.
Muller MJ, Willmann O, Rieger A, Fenk A, Selberg O, Lautz HU,et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 1992; 102(6):2033–2041.PubMed
35.
Muller MJ, Bottcher J, Selberg O, Weselmann S, Boker KH, Schwarze M,et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999;69(6):1194–1201.PubMed
36.
Schneeweiss B, Graninger W, Ferenci P, Eichinger S, Grimm G, Schneider B,et al. Energy metabolism in patients with acute and chronic liver disease. Hepatology 1990;11(3):387–393.PubMedCrossRef
37.
Owen OE, Reichle FA, Mozzoli MA, Kreulen T, Patel MS, Elfenbein IB,et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest 1981;68(1):240–252.PubMedCentralPubMedCrossRef
38.
Owen OE, Trapp VE, Reichard GA Jr, Mozzoli MA, Moctezuma J, Paul P,et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983;72(5):1821–1832.PubMedCentralPubMedCrossRef
39.
39 Swart GR, Berg JW Van Den, Vuure JK van, Rietveld T, Wattimena DL, Frenkel M. Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr 1989;8(6):329–336.PubMedCrossRef
40.
Swart GR, Zillikens MC, Vuure JK van, Berg JW Van Den. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989; 299(6709):1202–1203.PubMedCentralPubMedCrossRef
41.
Scolapio JS, Bowen J, Stoner G, Tarrosa V. Substrate oxidation in patients with cirrhosis: comparison with other nutritional markers. J Parenter Enteral Nutr 2000;24(3):150–153.CrossRef
42.
Muller MJ. Hepatic energy and substrate metabolism: a possible metabolic basis for early nutritional support in cirrhotic patients. Nutrition 1998;14(1):30–38.PubMedCrossRef
43.
Kondrup J, Muller MJ. Energy and protein requirements of patients with chronic liver disease. J Hepatol 1997;27(1):239–247.PubMedCrossRef
44.
Hayashi M, Ohnishi H, Kawade Y, Muto Y, Takahashi Y. Augmented utilization of branched–chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication. Gastroenterol Jpn 1981;16(1):64–70.PubMed
45.
Tessari P, Barazzoni R, Kiwanuka E, Davanzo G, De Pergola G, Orlando R,et al. Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis. Am J Physiol Endocrinol Metab 2002;282(2):E304–E311.PubMedCrossRef
46.
Cabré E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Banares F,et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990;98(3):715–720.PubMed
47.
Kearns PJ, Young H, Garcia G, Blaschke T, O’Hanlon G, Rinki M,et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992;102(1):200–205.PubMed
48.
Bunout D, Aicardi V, Hirsch S, Petermann M, Kelly M, Silva G,et al. Nutritional support in hospitalized patients with alcoholic liver disease. Eur J Clin Nutr 1989;43(9):615–621.PubMed
49.
Nasrallah SM, Galambos JT. Aminoacid therapy of alcoholic hepatitis. Lancet 1980;2(8207):1276–1277.PubMedCrossRef
50.
Mezey E, Caballeria J, Mitchell MC, Pares A, Herlong HF, Rodes J. Effect of parenteral amino acid supplementation on short–term and long–term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991;14(6):1090–1096.PubMedCrossRef
51.
Naveau S, Pelletier G, Poynard T, Attali P, Poitrine A, Buffet C,et al. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology 1986;6(2):270–274.PubMedCrossRef
52.
Diehl AM, Boitnott JK, Herlong HF, Potter JJ, Van Duyn MA, Chandler E,et al. Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 1985;5(1):57–63.PubMedCrossRef
53.
Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos JT. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short–term effects on liver function. Am J Gastroenterol 1991;86(9):1200–1208.PubMed
54.
Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J,et al. ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006;25(2):285–294.PubMedCrossRef
55.
Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F,et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004;41(1):38–43.PubMedCrossRef
56.
Verboeket-van de Venne WP, Westerterp KR, Hoek B van, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut 1995;36(1):110–116.CrossRef
57.
Zillekens MC, Berg JWO Van Den, Swart GR. The effect of nocturnal oral glucose supplementation on protein turnover in patients with cirrhosis of the liver. J Hepatol 1986;3(Suppl 1):S79.
58.
Chang WK, Chao YC, Tang HS, Lang HF, Hsu CT. Effects of extra–carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. J Parenter Enteral Nutr 1997;21(2):96–99.CrossRef
59.
Bianchi GP, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Zoli M,et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross–over comparison. J Intern Med 1993;233(5):385–392.PubMedCrossRef
60.
Liu Q, Duan ZP, Ha dK, Bengmark S, Kurtovic J, Riordan SM. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39(5):1441–1449.PubMedCrossRef
61.
Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S,et al. Supply of pre– and probiotics reduces bacterial infection rates after liver transplantation – a randomized, double–blind trial. Am J Transplant 2005;5(1):125–130.PubMedCrossRef
62.
63.
Fischer JE. 1996 Jonathan E. Rhoads Lecture. Mechanism, mechanism, mechanism. J Parenter Enteral Nutr 1996;20(5):319–324.CrossRef
64.
Jalan R, Seery JP, Taylor-Robinson SD. Review article: pathogenesis and treatment of chronic hepatic encephalopathy. Aliment Pharmacol Ther 1996;10(5):681–697.PubMedCrossRef
65.
66.
Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet 1984;2(8401): 493–495.PubMedCrossRef
67.
Scholmerich J, Langenberger G, Steiert B,et al. Long term zinc substitution in patients with zinc deficiency in liver cirrhosis – results of a placebo controlled trial. Gastroenterology 1986;90:1765.
68.
Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G,et al. Short–term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double–blind crossover trial. Dig Dis Sci 1991;36(9):1204–1208.PubMedCrossRef
69.
Bresci G, Parisi G, Banti S. Management of hepatic encephalopathy with oral zinc supplementation: a long–term treatment. Eur J Med 1993;2(7):414–416.PubMed
70.
Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid–nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996;23(5):1084–1092.PubMedCrossRef
71.
Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2(7715):75–80.PubMedCrossRef
72.
James JH, Ziparo V, Jeppsson B, Fischer JE. Hyperammonaemia, plasma aminoacid imbalance, and bloodbrain aminoacid transport: a unified theory of portalsystemic encephalopathy. Lancet 1979;2(8146):772–775.PubMedCrossRef
73.
Naylor CD, O’Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched–chain amino acids in hepatic encephalopathy. A meta–analysis. Gastroenterology 1989;97(4):1033–1042.PubMed
74.
Eriksson LS, Conn HO. Branched–chain amino acids in the management of hepatic encephalopathy: an analysis of variants. Hepatology 1989;10(2):228–246.PubMedCrossRef
75.
Morgan MY, Hawley KE, Stambuk D. Amino acid tolerance in cirrhotic patients following oral protein and amino acid loads. Aliment Pharmacol Ther 1990; 4(2):183–200.PubMedCrossRef
76.
Morgan MY. Branched chain amino acids in the management of chronic liver disease. Facts and fantasies. J Hepatol 1990;11(2):133–141.PubMedCrossRef
77.
Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched– chain amino acid treatment in chronic hepatic encephalopathy. J Parenter Enteral Nutr 1996;20(2): 159–164.CrossRef
78.
Berlin JA, Chalmers TC. Meta–analysis of branchedchain amino acids in hepatic encephalopathy. Gastroenterology 1989;97(4):1043–1045.PubMed
79.
Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched–chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2003;2:CD001939.PubMed
80.
Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C,et al. Nutritional supplementation with branched–chain amino acids in advanced cirrhosis: a double–blind, randomized trial. Gastroenterology 2003;124(7):1792–1801.PubMedCrossRef
81.
Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A,et al. Effects of oral branched–chain amino acid granules on event–free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005;3(7):705–713.PubMedCrossRef
82.
Chawla RK, Wolf DC, Kutner MH, Bonkovsky HL. Choline may be an essential nutrient in malnourished patients with cirrhosis. Gastroenterology 1989;97(6): 1514–1520.PubMed
83.
Teran JC, Mullen KD, McCullough AJ. Glutamine – a conditionally essential amino acid in cirrhosis? Am J Clin Nutr 1995;62(5):897–900.PubMed
84.
Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH,et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993;17(4):564–576.PubMedCrossRef
85.
Cabré E, Rodriguez-Iglesias P, Cabballeria J, Quer JC, Sanchez-Lombrana JL, Pares A,et al. Short– and longterm outcome of severe alcohol–induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2002;32(1):36–42.CrossRef
86.
Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. J Hepatol 1985;1(2):141–151.PubMedCrossRef
87.
88.
Nielsen K, Kondrup J, Martinsen L, Dossing H, Larsson B, Stilling B,et al. Long–term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 1995;74(4):557–567.PubMedCrossRef
89.
Reilly J, Mehta R, Teperman L, Cemaj S, Tzakis A, Yanaga K,et al. Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr 1990;14(4):386–391.PubMedCrossRef
Metagegevens
Titel
8 Leverziekten, ondervoeding en voeding
Auteur
Prof.dr. E.M.H. Mathus-Vliegen
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
Boek
Leverziekten

Print ISBN: 978-90-313-7436-6

Elektronisch ISBN: 978-90-313-7437-3

Copyright: 2009

DOI
https://doi.org/10.1007/978-90-313-7437-3_8